- Trials with a EudraCT protocol (89)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
89 result(s) found for: Electroencephalogram.
Displaying page 1 of 5.
| EudraCT Number: 2006-004764-31 | Sponsor Protocol Number: 02-2006 | Start Date*: 2007-01-11 |
| Sponsor Name:Max Planck Institute of Psychiatry | ||
| Full Title: Effects of corticotropin-releasing hormone on sleep electroencephalogram and sleep associated hormone secretion in young healthy women | ||
| Medical condition: Healthy volunteers. The aim is to test the effects of CRH on sleep electroencephalogram and sleep associated secretion of growth hormone and cortisol | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-003172-36 | Sponsor Protocol Number: 29.06.2011 | Start Date*: 2011-10-07 | |||||||||||||||||||||
| Sponsor Name:Department of Anaesthesia, Tampere University Hospital | |||||||||||||||||||||||
| Full Title: Arousal reaction during desflurane anaesthesia | |||||||||||||||||||||||
| Medical condition: The patients who undergo abdominal surgeries (laparotomy or laparoscopy) under desflurane anaesthesia will be investigated. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: FI (Prematurely Ended) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2006-001491-21 | Sponsor Protocol Number: 1-2006 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Max Planck Institute of Psychiatry | ||
| Full Title: Studies on Permeability of the Blood-Brain-Barrier for Escitaloprame related to various Genotypes of the ABCB1-Gene: Effects on Sleep and Motoric Learning | ||
| Medical condition: Effects on sleep electroencephalogram and motoric learning in healthy volunteers related to the permeability of the blood-brain-barrier related to genotypes of the ABCB 1 gene | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000945-37 | Sponsor Protocol Number: PIRAD-001 | Start Date*: 2017-05-01 |
| Sponsor Name:UMCG | ||
| Full Title: Pharmacodynamic interactions between remifentanil and dexmedetomidine (PIRAD) | ||
| Medical condition: We will include 30 healthy volunteers (American Society of Anesthesiologists 1) stratified to age groups to different sequence of anesthesia regimen | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-002824-19 | Sponsor Protocol Number: NA | Start Date*: 2021-08-12 |
| Sponsor Name:CHU de Liège | ||
| Full Title: Study of the hypnotic and anti-nociceptive components of Magnesium using Electroencephalogram Spectral Entropy and pupillometry during total intravenous general anesthesia : a randomized double-bli... | ||
| Medical condition: Total thyroidectomy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-002750-24 | Sponsor Protocol Number: N01269 | Start Date*: 2021-04-16 |
| Sponsor Name:UCB Biopharma SRL | ||
| Full Title: A Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study With a 2-Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Sa... | ||
| Medical condition: Childhood absence epilepsy and juvenile absence epilepsy | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: PL (Completed) BE (Completed) IT (Trial now transitioned) SK (Trial now transitioned) Outside EU/EEA ES (Trial now transitioned) RO (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-004956-32 | Sponsor Protocol Number: E2090-S082-404 | Start Date*: 2017-02-23 |
| Sponsor Name:Eisai Korea Inc. | ||
| Full Title: A Multi-center Comparative Trial of Low and High Dose Zonisamide in Children with Newly Diagnosed Epilepsy as Monotherapy | ||
| Medical condition: Epilepsy | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-003728-39 | Sponsor Protocol Number: OTMother2014 | Start Date*: 2014-12-16 |
| Sponsor Name:Tampere University Hospital | ||
| Full Title: Effects of maternal oxytocin on social information processing in mothers | ||
| Medical condition: There are no medical conditions or diseases under investigation, participants are healthy volunteers. | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-004379-22 | Sponsor Protocol Number: SP0961 | Start Date*: 2015-03-10 | |||||||||||
| Sponsor Name:UCB BIOSCIENCES, Inc. | |||||||||||||
| Full Title: An Open-Label Pilot Study to Assess the Safety of Oral Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects With Idiopathic Generalized Epilepsy | |||||||||||||
| Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: Outside EU/EEA | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-023668-42 | Sponsor Protocol Number: CRI 102194 | Start Date*: 2011-02-03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:Southampton University Hospital NHS Trust | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: Pulmonary surfactant (S) biology in ventilated children on a paediatric intensive care unit with acute (A) hypoxic respiratory (R) failure- a pilot (P) study (S): (SARPS) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: acute hypoxic respiratory failure in children ventilated on paediatric intensive care | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2016-004952-30 | Sponsor Protocol Number: E2080-J081-304 | Start Date*: 2017-02-13 |
| Sponsor Name:Eisai Co, Ltd. | ||
| Full Title: A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients | ||
| Medical condition: Lennox-Gastaut Syndrome (LSG) | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2014-001560-35 | Sponsor Protocol Number: 2358 | Start Date*: 2016-04-07 |
| Sponsor Name:Brain Center Rudolf Magnus, University Medical Center Utrecht, Department of Psychiatry, Utrecht , the Netherlands | ||
| Full Title: Bumetanide in Autism Medication and BIomarker study | ||
| Medical condition: Autism Spectrum Disorder | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-002010-35 | Sponsor Protocol Number: TinnEx | Start Date*: 2006-12-14 |
| Sponsor Name:Prof. Herta Flor, Head of the Institute of Clinical and Cognitive Neuroscience | ||
| Full Title: An Extinction Training in Tinnitus | ||
| Medical condition: The effect of pregabalin on the success to reduce the interference by tinnitus by an extinction training is tested in chronic tinnitus sufferers. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-001777-86 | Sponsor Protocol Number: 91710346.1.2 | Start Date*: 2012-10-23 |
| Sponsor Name: | ||
| Full Title: Pilot study for classification of attempted movement from the electroencephalogram in healthy participants with a temporary paralysis of one arm induced by local administration of rocuronium | ||
| Medical condition: Intraoperative awareness during general anesthesia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001592-20 | Sponsor Protocol Number: 91710346.2.1 | Start Date*: 2013-07-25 |
| Sponsor Name: | ||
| Full Title: Pilot study for studying the influence of low-dose propofol on the classification of movements from the electroencephalogram in healthy participants | ||
| Medical condition: Intraoperative awareness during general anesthesia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004552-37 | Sponsor Protocol Number: 18CH052 | Start Date*: 2019-05-07 | |||||||||||
| Sponsor Name:CHU SAINT-ETIENNE | |||||||||||||
| Full Title: Dose Study of Tranexamic Acid in Total Hip Replacement to Reduce Postoperative Hemoglobin Loss. A Phase 2 Randomized Double-blind Monocentric Study | |||||||||||||
| Medical condition: Arthropathy of Hip | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-014620-36 | Sponsor Protocol Number: Kotoe_2 | Start Date*: 2009-12-17 | ||||||||||||||||||||||||||||||||||||
| Sponsor Name:Tampere University Hospital | ||||||||||||||||||||||||||||||||||||||
| Full Title: Electroencephalogram during increasing and decreasing desflurane concentration | ||||||||||||||||||||||||||||||||||||||
| Medical condition: Surgical patients scheduled for elective surgery under general anaesthesia. Otherwise in stable medical condition (ASA status less than 3) | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
| Trial protocol: FI (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2020-001066-10 | Sponsor Protocol Number: SP0968 | Start Date*: 2021-09-06 |
| Sponsor Name:UCB Biopharma SRL | ||
| Full Title: A Multicenter, Open-Label, Randomized, Active Comparator Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures | ||
| Medical condition: Electroencephalographic Neonatal Seizures (ENS) | ||
| Disease: | ||
| Population Age: Newborns, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-000222-19 | Sponsor Protocol Number: H2020-PHC-18-2015-667224 | Start Date*: 2017-08-02 | ||||||||||||||||
| Sponsor Name:University Hospital Tuebingen | ||||||||||||||||||
| Full Title: Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome – a blinded randomized placebo-controlled parallel group multicenter trial for superiori... | ||||||||||||||||||
| Medical condition: Perinatal Asphyxia, hypoxic-ischemic brain injury | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Trial now transitioned) NL (Trial now transitioned) NO (Trial now transitioned) ES (Ongoing) FI (Trial now transitioned) EE (Trial now transitioned) AT (Trial now transitioned) BE (Trial now transitioned) PT (Prematurely Ended) IT (Trial now transitioned) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2019-001331-31 | Sponsor Protocol Number: ZX008-1900 | Start Date*: 2019-11-07 | ||||||||||||||||
| Sponsor Name:Zogenix International Limited | ||||||||||||||||||
| Full Title: An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy for Seizures in Patients with Rare Seizure Disorders Such a... | ||||||||||||||||||
| Medical condition: Dravet syndrome or Lennox-Gastaut syndrome | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) DK (Completed) FR (Completed) ES (Ongoing) DE (Completed) SE (Completed) NL (Trial now transitioned) PL (Trial now transitioned) IT (Trial now transitioned) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
